Company / Depreciation & Amortization
Bicara Therapeutics Inc. Depreciation & Amortization History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$56.0K
FY2024
5-year range
$19.0K / $56.0K
FY2023-FY2024
Trend
+194.7%
vs FY2023
Sector context
#158 of 163
Health Care
What the data says
Among 163 Health Care companies, Bicara Therapeutics Inc. is in the top 3% for depreciation & amortization.
Based on SEC 10-K filings.
$56,000 in FY2024.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 163This company $56.0K Sector average $219.4M
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2024, depreciation & amortization increased 194.7% year-over-year.
- Ranks #158 out of 163 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 11.58 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $56.0K | +194.7% |
| FY2023 | $19.0K | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026